Couragene Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1M
- Investors
-
2
Couragene General Information
Description
Developer of a gene delivery platform designed to provide gene therapy. The company's technology provides oral drug delivery technology and gene medicine that leverages chemical engineering approaches to efficient intracellular delivery of genetic medicine payloads, such as proteins, gene editors, antibodies, mRNA, antisense oligos (ASOs), and DNA, enabling healthcare to overcome the delivery hurdles for the treatment of various diseases, including neurogenetic disorders.
Contact Information
Website
www.couragene.comCorporate Office
- New Jersey Bioscience Center
- 675 US Highway 1
- North Brunswick, NJ 08902
- United States
Corporate Office
- New Jersey Bioscience Center
- 675 US Highway 1
- North Brunswick, NJ 08902
- United States
Couragene Timeline
Couragene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 20-May-2024 | $1M | Completed | Generating Revenue | ||
| 1. Seed Round | 06-Sep-2022 | Completed | Generating Revenue |
Couragene Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed III | ||||||||
| Seed II | ||||||||
| Seed I | 4,000,000 | $0.000000 | $1 | $1 | 1x | $1 | 24.51% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Couragene Patents
Couragene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260191973-A1 | Stimuli-responsive engineering platform for intracellular payload delivery | Pending | 09-Jan-2025 | ||
| WO-2026151823-A2 | Stimuli-responsive engineering platform for intracellular payload delivery | Pending | 09-Jan-2025 | ||
| WO-2026151823-A3 | Stimuli-responsive engineering platform for intracellular payload delivery | Pending | 09-Jan-2025 | ||
| WO-2025245094-A2 | Peptide sequences for improved delivery of proteins into nucleus | Pending | 21-May-2024 | C12N9/226 |
Couragene Signals
Couragene Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Foothill Ventures | Venture Capital | Minority | ||
| Hi2 Global | Venture Capital | Minority |
Couragene Investments (1)
Couragene’s most recent deal was a Joint Venture with CourageAS Biotherapeutics. The deal was made on 14-Feb-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CourageAS Biotherapeutics | 14-Feb-2025 | Joint Venture | Drug Discovery |
Couragene FAQs
-
When was Couragene founded?
Couragene was founded in 2022.
-
Where is Couragene headquartered?
Couragene is headquartered in North Brunswick, NJ.
-
What is the size of Couragene?
Couragene has 5 total employees.
-
What industry is Couragene in?
Couragene’s primary industry is Drug Delivery.
-
Is Couragene a private or public company?
Couragene is a Private company.
-
What is the current valuation of Couragene?
The current valuation of Couragene is .
-
What is Couragene’s current revenue?
The current revenue for Couragene is .
-
How much funding has Couragene raised over time?
Couragene has raised $3.6M.
-
Who are Couragene’s investors?
Foothill Ventures and Hi2 Global have invested in Couragene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process